How metastatic cancer cells escape immune system detection through EMT
A Review Paper
DOI:
https://doi.org/10.47611/jsrhs.v13i3.7087Keywords:
cancer, metastasis, EMT, immune systemAbstract
The global prevalence of cancer and its consequential mortality underscores the urgency of understanding the metastatic process, a primary cause of cancer-related deaths. Metastasis, characterized by the spread of cancer cells to distant sites, often involves immune evasion mechanisms facilitating uncontrolled growth. Epithelial-mesenchymal transition (EMT) is a pivotal process enabling metastatic cells to detach from the primary tumor and migrate. EMT induces alterations in surface molecule expression, impairing immune cell recognition. This transition also affects the tumor microenvironment, leading to immune-suppressive cytokine release. The need to investigate EMT-mediated immune evasion is immediate, as it is crucial for developing novel strategies to combat metastatic cancer by targeting these evasive mechanisms. This review aims to summarize molecular changes during EMT, evaluate its impact on surface molecules and the tumor microenvironment that helps it escape from the immune system, and offer insights for devising strategies to target EMT-driven metastatic cells.
Downloads
References or Bibliography
Adams, Jerry L., James Smothers, Roopa Srinivasan, and Axel Hoos. 2015. “Big Opportunities for Small Molecules in Immuno-Oncology.” Nature Reviews. Drug Discovery 14 (9): 603–22.
Arnedos, Monica, Cecile Vicier, Sherene Loi, Celine Lefebvre, Stefan Michiels, Herve Bonnefoi, and Fabrice Andre. 2015. “Precision Medicine for Metastatic Breast Cancer—limitations and Solutions.” Nature Reviews. Clinical Oncology 12 (12): 693–704.
Babaei, Ghader, Shiva Gholizadeh-Ghaleh Aziz, and Nasrin Zare Zavieyh Jaghi. 2021. “EMT, Cancer Stem Cells and Autophagy; The Three Main Axes of Metastasis.” Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 133 (January): 110909.
Chang, Xuechun, Kexin Jiao, Danjie Wang, Yufan Zhou, Zhao Zhao, Ying Xing, Jingzi Zhangbao, Chuanzhen Lu, Jun Wang, and Chao Quan. 2023. “The Immune Imbalance between Follicular Regulatory and Helper T Cells in Myelin Oligodendrocyte Glycoprotein IgG-Associated Disease.” Clinical Immunology , August, 109734.
Coussens, Lisa M., and Zena Werb. 2002. “Inflammation and Cancer.” Nature 420 (6917): 860–67.
Crystal, Ronald G., Scott H. Randell, John F. Engelhardt, Judith Voynow, and Mary E. Sunday. 2008. “Airway Epithelial Cells: Current Concepts and Challenges.” Proceedings of the American Thoracic Society 5 (7): 772–77.
Deugnier, Marie-Ange, Jérôme Teulière, Marisa M. Faraldo, Jean Paul Thiery, and Marina A. Glukhova. 2002. “The Importance of Being a Myoepithelial Cell.” Breast Cancer Research: BCR 4 (6): 224–30.
Dr. Otis Brawley: Fighting Patient Mistreatment in U.S. (Commonwealth Club). 2014. Kanopy Streaming.
Galli, Filippo, Jesus Vera Aguilera, Belinda Palermo, Svetomir N. Markovic, Paola Nisticò, and Alberto Signore. 2020. “Relevance of Immune Cell and Tumor Microenvironment Imaging in the New Era of Immunotherapy.” Journal of Experimental & Clinical Cancer Research: CR 39 (1): 89.
Gough, Michael J., and Marka R. Crittenden. 2012. “Immune System Plays an Important Role in the Success and Failure of Conventional Cancer Therapy.” Immunotherapy 4 (2): 125–28.
Haan, Joke M. M. den, Ramon Arens, and Menno C. van Zelm. 2014. “The Activation of the Adaptive Immune System: Cross-Talk between Antigen-Presenting Cells, T Cells and B Cells.” Immunology Letters 162 (2 Pt B): 103–12.
Halbrook, Christopher J., Costas A. Lyssiotis, Marina Pasca di Magliano, and Anirban Maitra. 2023. “Pancreatic Cancer: Advances and Challenges.” Cell 186 (8): 1729–54.
Hanahan, Douglas, and Robert A. Weinberg. 2011. “Hallmarks of Cancer: The next Generation.” Cell 144 (5): 646–74.
Han, Joungho, Kyung Soo Lee, Chin A. Yi, Tae Sung Kim, Young Mog Shim, Jhingook Kim, Kwhanmien Kim, and O. Jung Kwon. 2003. “Thymic Epithelial Tumors Classified according to a Newly Established WHO Scheme: CT and MR Findings.” Korean Journal of Radiology: Official Journal of the Korean Radiological Society 4 (1): 46–53.
Hay, E. D. 1991. Cell Biology of Extracellular Matrix: Second Edition. Springer Science & Business Media.
Henderson, Brian E., Bruce Ponder, and Ronald K. Ross. 2003. Hormones, Genes, and Cancer. Oxford University Press.
Hiemstra, Pieter S., Paul B. McCray Jr, and Robert Bals. 2015. “The Innate Immune Function of Airway Epithelial Cells in Inflammatory Lung Disease.” The European Respiratory Journal: Official Journal of the European Society for Clinical Respiratory Physiology 45 (4): 1150–62.
Islam, Farhadul, and Alfred K. Lam. 2023. Cancer Stem Cells: Basic Concept and Therapeutic Implications. Springer Nature.
Krieghoff-Henning, Eva, Juliane Folkerts, Andrea Penzkofer, and Susanne Weg-Remers. 2017. “Cancer – an Overview.” Medizinische Monatsschrift Fur Pharmazeuten 40 (2): 48–54.
Krzyszczyk, Paulina, Alison Acevedo, Erika J. Davidoff, Lauren M. Timmins, Ileana Marrero-Berrios, Misaal Patel, Corina White, et al. 2018. “The Growing Role of Precision and Personalized Medicine for Cancer Treatment.” Technology 6 (3-4): 79–100.
Kurn, Heidi, and Daniel T. Daly. 2023. “Histology, Epithelial Cell.” In StatPearls. Treasure Island (FL): StatPearls Publishing.
Liang, Chao, Ligeng Xu, Guosheng Song, and Zhuang Liu. 2016. “Emerging Nanomedicine Approaches Fighting Tumor Metastasis: Animal Models, Metastasis-Targeted Drug Delivery, Phototherapy, and Immunotherapy.” Chemical Society Reviews 45 (22): 6250–69.
Li, Dan, Xue Li, Wei-Lin Zhou, Yong Huang, Xiao Liang, Lin Jiang, Xiao Yang, et al. 2019. “Genetically Engineered T Cells for Cancer Immunotherapy.” Signal Transduction and Targeted Therapy 4 (September): 35.
Lim, Jormay, and Jean Paul Thiery. 2012. “Epithelial-Mesenchymal Transitions: Insights from Development.” Development 139 (19): 3471–86.
Li, Xiaoyun, Mathias Wenes, Pedro Romero, Stanley Ching-Cheng Huang, Sarah-Maria Fendt, and Ping-Chih Ho. 2019. “Navigating Metabolic Pathways to Enhance Antitumour Immunity and Immunotherapy.” Nature Reviews. Clinical Oncology 16 (7): 425–41.
Li, Yan-Ruide, Zachary Spencer Dunn, Yang Zhou, Derek Lee, and Lili Yang. 2021. “Development of Stem Cell-Derived Immune Cells for Off-the-Shelf Cancer Immunotherapies.” Cells 10 (12). https://doi.org/10.3390/cells10123497.
Luzzi, K. J., I. C. MacDonald, E. E. Schmidt, N. Kerkvliet, V. L. Morris, A. F. Chambers, and A. C. Groom. 1998. “Multistep Nature of Metastatic Inefficiency: Dormancy of Solitary Cells after Successful Extravasation and Limited Survival of Early Micrometastases.” The American Journal of Pathology 153 (3): 865–73.
Maclean, Norman. 1977. The Differentiation of Cells. E. Arnold.
Mason, Chris, and Peter Dunnill. 2008. “A Brief Definition of Regenerative Medicine.” Regenerative Medicine 3 (1): 1–5.
Massagué, Joan, and Anna C. Obenauf. 2016. “Metastatic Colonization by Circulating Tumour Cells.” Nature 529 (7586): 298–306.
McGranahan, Nicholas, and Charles Swanton. 2017. “Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future.” Cell 168 (4): 613–28.
Mulholland, David J., Naoko Kobayashi, Marcus Ruscetti, Allen Zhi, Linh M. Tran, Jiaoti Huang, Martin Gleave, and Hong Wu. 2012. “Pten Loss and RAS/MAPK Activation Cooperate to Promote EMT and Metastasis Initiated from Prostate Cancer Stem/progenitor Cells.” Cancer Research 72 (7): 1878–89.
Multhoff, G., C. Botzler, M. Wiesnet, E. Müller, T. Meier, W. Wilmanns, and R. D. Issels. 1995. “A Stress-Inducible 72-kDa Heat-Shock Protein (HSP72) Is Expressed on the Surface of Human Tumor Cells, but Not on Normal Cells.” International Journal of Cancer. Journal International Du Cancer 61 (2): 272–79.
Niederman, M. S., T. D. Rafferty, C. T. Sasaki, W. W. Merrill, R. A. Matthay, and H. Y. Reynolds. 1983. “Comparison of Bacterial Adherence to Ciliated and Squamous Epithelial Cells Obtained from the Human Respiratory Tract.” The American Review of Respiratory Disease 127 (1): 85–90.
Prigge, Justin R., Teri R. Hoyt, Erin Dobrinen, Mario R. Capecchi, Edward E. Schmidt, and Nicole Meissner. 2015. “Type I IFNs Act upon Hematopoietic Progenitors To Protect and Maintain Hematopoiesis during Pneumocystis Lung Infection in Mice.” Journal of Immunology 195 (11): 5347–57.
Riva, Gabriele, Simona Baronchelli, Laura Paoletta, Valentina Butta, Ida Biunno, Marialuisa Lavitrano, Leda Dalprà, and Angela Bentivegna. 2014. “In Vitro Anticancer Drug Test: A New Method Emerges from the Model of Glioma Stem Cells.” Toxicology Reports 1 (May): 188–99.
Roy, P. S., and B. J. Saikia. 2016. “Cancer and Cure: A Critical Analysis.” Indian Journal of Cancer 53 (3): 441–42.
Sathananthan, Professor Arunachalam Henry. 2015. HUMAN CELL AND TISSUE FINE STRUCTURE FOR TEACHING AND RESEARCH IN STEM CELLS. Professor Arunachalam Henry Sathananthan.
Somensi, Nauana, Pedro Ozorio Brum, Vitor de Miranda Ramos, Juciano Gasparotto, Alfeu Zanotto-Filho, Diana Carolina Rostirolla, Maurilio da Silva Morrone, José Claudio Fonseca Moreira, and Daniel Pens Gelain. 2017. “Extracellular HSP70 Activates ERK1/2, NF-kB and Pro-Inflammatory Gene Transcription Through Binding with RAGE in A549 Human Lung Cancer Cells.” Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology 42 (6): 2507–22.
Steeg, Patricia S. 2006. “Tumor Metastasis: Mechanistic Insights and Clinical Challenges.” Nature Medicine 12 (8): 895–904.
Terry, Stéphane, Pierre Savagner, Sandra Ortiz-Cuaran, Linda Mahjoubi, Pierre Saintigny, Jean-Paul Thiery, and Salem Chouaib. 2017. “New Insights into the Role of EMT in Tumor Immune Escape.” Molecular Oncology 11 (7): 824–46.
Times, O. 2022. “Shop Talk.” Oncology Times 44 (11): 36–37.
Uchinomiya, Kouki, and Masanori Tomita. 2023. “A Mathematical Model for Cancer Risk and Accumulation of Mutations Caused by Replication Errors and External Factors.” PloS One 18 (6): e0286499.
United States. Congress. Senate. Committee on Environment and Public Works. 1994. Nominations of Frederic J. Hansen, Paul L. Hill, Devra Lee Davis, Gerald V. Poje, Anne J. Udall, Ronald K. Burton, and David M. Rappoport: Hearing Before the Committee on Environment and Public Works, United States Senate, One Hundred Third Congress, Second Session, on the Nominations of Frederic J. Hansen, to Be Deputy Administrator, Environmental Protection Agency; Paul L. Hill ... the Chemical Safety Board, and Anne J. Udall ... the Board of Directors, Morris K. Udall Foundation, September 27, 1994. U.S. Government Printing Office.
Weigelt, B., L. F. A. Wessels, A. J. Bosma, A. M. Glas, D. S. A. Nuyten, Y. D. He, H. Dai, J. L. Peterse, and L. J. van’t Veer. 2005. “No Common Denominator for Breast Cancer Lymph Node Metastasis.” British Journal of Cancer 93 (8): 924–32.
Welch, Danny R., and Douglas R. Hurst. 2019. “Defining the Hallmarks of Metastasis.” Cancer Research 79 (12): 3011–27.
Wilkerson, Amy, Kathaliya Wongsatittham, and Josephine Johnston. 2013. “The NIH Stem Cell Registry: An Absence of Gamete Donor Consent.” Cell Stem Cell 12 (2): 147–48.
Yu, Wenqi, Xueqin He, Zhihang Yang, Xiaotong Yang, Wei Xiao, Rui Liu, Rou Xie, Lin Qin, and Huile Gao. 2019. “Sequentially Responsive Biomimetic Nanoparticles with Optimal Size in Combination with Checkpoint Blockade for Cascade Synergetic Treatment of Breast Cancer and Lung Metastasis.” Biomaterials 217 (October): 119309.
Zhang, Pengcheng, Yihui Zhai, Ying Cai, Yuliang Zhao, and Yaping Li. 2019. “Nanomedicine-Based Immunotherapy for the Treatment of Cancer Metastasis.” Advanced Materials 31 (49): e1904156.
Published
How to Cite
Issue
Section
Copyright (c) 2024 YIGIT KAAN KIZLIER
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright holder(s) granted JSR a perpetual, non-exclusive license to distriute & display this article.
